What is the long-term trend for 10x Genomics, Inc.'s share-based payment - nonvested awards (number)?

Over 5 years (2020 to 2025), 10x Genomics, Inc.'s share-based payment - nonvested awards (number) has grown at a 56.9% compound annual growth rate (CAGR), from 823.9K to 7.8M.

10x Genomics, Inc. TXG Share-Based Payment - Nonvested Awards (Number)

Share-Based Payment - Nonvested Awards (Number) at other companies

Flagstar Bank FLG

2.8M-59.3%

Lantheus HoldingsLNTH

1.2M-2.4%

Polaryx Therapeutics, Inc. PLYX

$4.19M+56.7%

McDonald'sMCD

1.2M0.0%

International PaperIP

5.4M-21.8%

SBA CommunicationsSBAC

14K-30.0%

Other financials

Income statement

See full

Revenue$150.8M-2.6%

Gross profit$106.2M+0.7%

Operating income-$17.0M+56.7%

Net income-$13.5M+60.8%

EPS (diluted)-$0.10+64.3%

Balance sheet

See full

Cash & equivalents$490.3M+30.0%

Total debt$81.4M+1.6%

Total equity$814.3M+15.2%

Total assets$1.0B+12.4%

Cash flow

See full

Operating cash flow$26.1M-24.0%

CapEx$1.6M-15.6%

Free cash flow$24.5M-24.4%

Valuation

See full

Market cap$4.41B+154%

Profitability

See full

Gross margin69.6%+1.2pp

Operating margin-6.1%-2.7pp

Net margin-3.5%-1.6pp

FCF margin19.1%—

Returns & leverage

See full

Return on equity-3%-1.4pp

Debt / equity0.1×0.0×

Current ratio5.9×+0.5×

Where this comes from

Reported directly by 10x Genomics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber.

The official record: 10x Genomics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about 10x Genomics, Inc.'s share-based payment - nonvested awards (number).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is 10x Genomics, Inc.'s share-based payment - nonvested awards (number)?: 10x Genomics, Inc. (TXG) reported share-based payment - nonvested awards (number) of 8M in Q1 2026.
How has 10x Genomics, Inc.'s share-based payment - nonvested awards (number) changed year-over-year?: 10x Genomics, Inc.'s share-based payment - nonvested awards (number) increased by 4.6% year-over-year, from 7.6M to 8M.
What is the long-term trend for 10x Genomics, Inc.'s share-based payment - nonvested awards (number)?: Over 5 years (2020 to 2025), 10x Genomics, Inc.'s share-based payment - nonvested awards (number) has grown at a 56.9% compound annual growth rate (CAGR), from 823.9K to 7.8M.